June 23, 2026
Syntax Bio
Syntax Bio raised $14.4 million in Series A expansion funding to advance stem cell therapies for Type 1 diabetes with support from Mayo Clinic.
- Round
- Series A
- Amount raised
- $14.4M
- Lead investor
- —
- Industry
- Biotechnology, Healthcare
- Headquarters
- —
- Employees
- —
- Website
- www.syntax-bio.com
- View profile →